Clinical trial
Patients Preference With Self-Injection: The PRISM Study
NCT00253396 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00253396 |
|---|---|
| Title | Patients Preference With Self-Injection: The PRISM Study |
| Official title | THE PRISM Study-Low-Molecular-Weight Heparin Versus Unfractionated Heparin for Perioperative Bridging Anticoagulation: the Patient Preference for Self-Injection Study and Related Measurements |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | St. Joseph's Health Care London |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bruises |
| Intervention type | Drug |
| Interventions | Unfractionated heparin, Enoxaparin |
| Enrollment | 100 |
| Start date | Oct 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Nov 15, 2005 |
| Last update posted | Mar 10, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: